Synthesis and In Vitro Testing of YVO(4):Eu(3+)@silica-NH-GDA-IgG Bio-Nano Complexes for Labelling MCF-7 Breast Cancer Cells

合成及体外测试 YVO(4):Eu(3+)@二氧化硅-NH-GDA-IgG 生物纳米复合物用于标记 MCF-7 乳腺癌细胞

阅读:2

Abstract

We present a visual tool and facile method to detect MCF-7 breast cancer cells by using YVO(4):Eu(3+)@silica-NH-GDA-IgG bio-nanocomplexes. To obtain these complexes, YVO(4):Eu(3+) nanoparticles with a uniform size of 10-25 nm have been prepared firstly by the hydrothermal process, followed by surface functionalization to be bio-compatible and conjugated with cancer cells. The YVO(4):Eu(3+)@silica-NH-GDA-IgG nanoparticles exhibited an enhanced red emission at 618 nm under an excitation wavelength of 355 nm and were strongly coupled with MCF-7 breast cancer cells via biological conjugation. These bio-nanocomplexes showed a superior sensitiveness for MCF-7 cancer cell labelling with a detection percentage as high as 82%, while no HEK-293A healthy cells were probed under the same conditions of in vitro experiments. In addition, the detection percentage of MCF-7 breast cancer cells increased significantly via the functionalization and conjugation of YVO(4):Eu(3+) nanoparticles. The experimental results demonstrated that the YVO(4):Eu(3+)@silica-NH-GDA-IgG bio-nanocomplexes can be used as a promising labelling agent for biomedical imaging and diagnostics.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。